(19)
(11) EP 2 225 559 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.12.2016 Bulletin 2016/51

(45) Mention of the grant of the patent:
16.11.2016 Bulletin 2016/46

(21) Application number: 07866274.9

(22) Date of filing: 28.12.2007
(51) International Patent Classification (IPC): 
G01N 33/53(2006.01)
(86) International application number:
PCT/EP2007/011462
(87) International publication number:
WO 2009/083020 (09.07.2009 Gazette 2009/28)

(54)

ASSESSMENT OF PHYSIOLOGICAL CONDITIONS

BEURTEILUNG PHYSIOLOGISCHER BEDINGUNGEN

EVALUATION D'ÉTATS PHYSIOLOGIQUES


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(43) Date of publication of application:
08.09.2010 Bulletin 2010/36

(73) Proprietors:
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)
    Designated Contracting States:
    AT BE BG CH CY CZ DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR 
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)
    Designated Contracting States:
    DE 

(72) Inventors:
  • BIEGLMAYER, Christian
    1170 Wien (AT)
  • KUDLACEK, Stefan
    A-1170 Wien (AT)

(74) Representative: Weickmann & Weickmann PartmbB 
Postfach 860 820
81635 München
81635 München (DE)


(56) References cited: : 
WO-A-01/22093
WO-A-02/096284
WO-A-96/12187
   
  • HAMWI AHMAD ET AL: "Markers of bone turnover in postmenopausal women receiving hormone replacement therapy" CLINICAL CHEMISTRY AND LABORATORY MEDICINE, vol. 39, no. 5, May 2001 (2001-05), pages 414-417, XP002477721 ISSN: 1434-6621
  • KIM SANG WAN ET AL: "Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis" ENDOCRINE JOURNAL, vol. 52, no. 6, December 2005 (2005-12), pages 667-674, XP002477722 ISSN: 0918-8959
  • EXNER ET AL: "Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol" JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ELSEVIER, NEW YORK, NY, US, vol. 47, no. 11, 6 June 2006 (2006-06-06), pages 2212-2218, XP005477440 ISSN: 0735-1097
  • KENJI TAKAHARA ET AL: "Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures" JOURNAL OF ORTHOPAEDIC SCIENCE ; OFFICIAL JOURNAL OF THE JAPANESE ORTHOPAEDIC ASSOCIATION, SPRINGER-VERLAG, TO, vol. 12, no. 3, 31 May 2007 (2007-05-31), pages 219-226, XP019519901 ISSN: 1436-2023
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).